[Pharmacological and psychosocial interventions for cannabis use disorders].
OBJECTIVE
Cannabis remains the most widely used illicit substance in most developed countries. Its addictive potential has been established and the need for interventions for cannabis-related problems has become apparent. This article provides a review of the research evaluating potential treatments for cannabis use disorders.


METHODS
A search of publication databases identified research studies and reviews of the scientific literature on psychosocial and pharmacological interventions for cannabis use disorders.


RESULTS
For adults, behaviorally-based interventions engender significant positive effects on abstinence and reductions in cannabis use. With adolescents, similar treatments and family-based interventions have demonstrated efficacy. Across studies, response rates appear modest even with the most potent psychosocial treatments. Evaluations of pharmacological approaches to cannabis use disorders have yet to provide clinical efficacy data for any specific medication. Agonist and antagonist approaches appear to offer the most promise. Advances in understanding of the neurobiology of the cannabinoid system provide optimism that the synthesis of compounds that alter CB(1) receptor site functioning may produce promising medications.


CONCLUSIONS
Clinical research has identified effective psychosocial treatments, but has yet to yield effective pharmacotherapies. Much work remains to enhance the potency of and access to interventions for those seeking treatment for cannabis use disorders.
Department of Psychiatry and Behavioral Sciences, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA. _ajbudney@uams.edu
Alan J
AJ
Budney
Ryan G
RG
Vandrey
Catherine
C
Stanger
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D006801:Humans; D002189:Marijuana Abuse / Q000628:therapy*; D011613:Psychotherapy / Q000379:methods*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy
D011619:Psychotropic Drugs